Israeli health-tech company MeMed has announced the successful development of a groundbreaking diagnostic tool that can quickly distinguish between bacterial and viral infections using just a finger prick.

The new product, called MeMed BV Flex, delivers results in 15 minutes and is designed for use in decentralized clinics and other point-of-care settings.

The test is an expansion of the company’s existing MeMed BV® platform and was validated in a prospective analytical study.